Gary G. Liversidge

Person

Charlestown, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Abuse-resistant pharmaceutical compositions
- Patent number 8,623,412
- Issue date Jan 7, 2014
- Elan Pharma International Limited
- Vaghefi Farid
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nanoparticulate carverdilol formulations
- Patent number 8,367,112
- Issue date Feb 5, 2013
- Alkermes Pharma Ireland Limited
- Gary Liversidge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nanoparticulate quinazoline derivative formulations
- Patent number 8,309,133
- Issue date Nov 13, 2012
- Alkermes Pharma Ireland Limited
- Gary G. Liversidge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Controlled-release nanoparticulate compositions
- Patent number 8,293,277
- Issue date Oct 23, 2012
- Alkermes Pharma Ireland Limited
- Jon Swanson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Glipizide compositions
- Patent number 8,236,352
- Issue date Aug 7, 2012
- Alkermes Pharma Ireland Limited
- H. William Bosch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nanoparticulate bisphosphonate compositions
- Patent number 8,158,153
- Issue date Apr 17, 2012
- Alkermes Pharma Ireland Limited
- Gary G. Liversidge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nanoparticulate and controlled release compositions comprising cefd...
- Patent number 8,119,163
- Issue date Feb 21, 2012
- Alkermes Pharma Ireland Limited
- John G Devane
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nanoparticulate corticosteroid and antihistamine formulations metho...
- Patent number 8,003,127
- Issue date Aug 23, 2011
- Elan Pharma International Limited
- Gary Liversidge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Injectable nanoparticulate olanzapine formulations
- Patent number 7,910,577
- Issue date Mar 22, 2011
- Elan Pharma International Limited
- Gary Liversidge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nanoparticulate and controlled release compositions comprising cycl...
- Patent number 7,825,087
- Issue date Nov 2, 2010
- Elan Pharma International Limited
- Scott A. Jenkins
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Reduction of intravenously administered nanoparticulate-formulation...
- Patent number RE41884
- Issue date Oct 26, 2010
- Elan Pharma International Limited
- Lawrence de Garavilla
- 424 - Drug, bio-affecting and body treating compositions
Information Patent Grant
Nanoparticulate polycosanol formulations and novel polycosanol comb...
- Patent number 7,763,278
- Issue date Jul 27, 2010
- Elan Pharma International Ltd.
- Eugene R. Cooper
- A23 - FOODS OR FOODSTUFFS THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
Information Patent Grant
Methods for targeting drug delivery to the upper and/or lower gastr...
- Patent number 6,432,381
- Issue date Aug 13, 2002
- Elan Pharma International Limited
- Gary G. Liversidge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating mammals using nanocrystalline formulations of h...
- Patent number 6,221,400
- Issue date Apr 24, 2001
- Elan Pharma International Limited
- Gary G. Liversidge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of making nanocrystalline formulations of human immunodefic...
- Patent number 6,068,858
- Issue date May 30, 2000
- Elan Pharma International Limited
- Gary G. Liversidge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nanocrystalline formulations of human immunodeficiency virus (HIV)...
- Patent number 6,045,829
- Issue date Apr 4, 2000
- Elan Pharma International Limited
- Gary G. Liversidge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Reduction of intravenously administered nanoparticulate-formulation...
- Patent number 5,834,025
- Issue date Nov 10, 1998
- NanoSystems L.L.C.
- Lawrence de Garavilla
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Formulations of oral gastrointestinal diagnostic x-ray contrast age...
- Patent number 5,628,981
- Issue date May 13, 1997
- Nano Systems L.L.C.
- Gary Liversidge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Barium salt formulations stabilized by non-ionic and anionic stabil...
- Patent number 5,593,657
- Issue date Jan 14, 1997
- NanoSystems LLC
- Stephen B. Ruddy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Formulations of oral gastrointestinal therapeutic agents in combina...
- Patent number 5,585,108
- Issue date Dec 17, 1996
- NanoSystems LLC
- Stephen B. Ruddy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Site-specific adhesion within the GI tract using nanoparticles stab...
- Patent number 5,580,579
- Issue date Dec 3, 1996
- Nano Systems L.L.C.
- Stephen B. Ruddy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Surface modified NSAID nanoparticles
- Patent number 5,552,160
- Issue date Sep 3, 1996
- NanoSystems LLC
- Gary G. Liversidge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Surface modified anticancer nanoparticles
- Patent number 5,494,683
- Issue date Feb 27, 1996
- Eastman Kodak Company
- Gary G. Liversidge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Formulations of oral gastrointestinal diagnostic X-ray contrast age...
- Patent number 5,466,440
- Issue date Nov 14, 1995
- Eastman Kodak Company
- Stephen B. Ruddy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
X-ray contrast compositions useful in medical imaging
- Patent number 5,451,393
- Issue date Sep 19, 1995
- Eastman Kodak Company
- Gary G. Liversidge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Surface modified anticancer nanoparticles
- Patent number 5,399,363
- Issue date Mar 21, 1995
- Eastman Kodak Company
- Gary G. Liversidge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
X-ray contrast compositions useful in medical imaging
- Patent number 5,318,767
- Issue date Jun 7, 1994
- Sterling Winthrop Inc.
- Gary G. Liversidge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method to reduce particle size growth during lyophilization
- Patent number 5,302,401
- Issue date Apr 12, 1994
- Sterling Winthrop Inc.
- Gary G. Liversidge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Surface modified drug nanoparticles
- Patent number 5,145,684
- Issue date Sep 8, 1992
- Sterling Drug Inc.
- Gary G. Liversidge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
ALCOHOL RESISTANT ENTERIC PHARMACEUTICAL COMPOSITIONS
- Publication number 20180085315
- Publication date Mar 29, 2018
- Alkermes Pharma Ireland Limited
- Gary Liversidge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Multiparticulate Modified Release Composition
- Publication number 20170000783
- Publication date Jan 5, 2017
- Recro Technology LLC
- John G. Devane
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INJECTABLE NANOPARTICULATE OLANZAPINE FORMULATIONS
- Publication number 20150238505
- Publication date Aug 27, 2015
- Alkermes Pharma Ireland Limited
- Stephen B. Ruddy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ALCOHOL RESISTANT ENTERIC PHARMACEUTICAL COMPOSITIONS
- Publication number 20140248341
- Publication date Sep 4, 2014
- Alkermes Pharma Ireland Limited
- Gary Liversidge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ABUSE-RESISTANT PHARMACEUTICAL COMPOSITIONS
- Publication number 20140112980
- Publication date Apr 24, 2014
- Farid Vaghefi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Injectable Nanoparticulate Olanzapine Formulations
- Publication number 20130309310
- Publication date Nov 21, 2013
- Alkermes Pharma Ireland Limited
- Stephen B. Ruddy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CONTROLLED RELEASE NANOPARTICULATE COMPOSITIONS
- Publication number 20130011447
- Publication date Jan 10, 2013
- Alkermes Pharma Ireland Limited
- Jon Swanson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INJECTABLE NANOPARTICULATE OLANZAPINE FORMULATIONS
- Publication number 20120315336
- Publication date Dec 13, 2012
- Alkermes Pharma Ireland Limited
- Stephen B. Ruddy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NANOPARTICULATE BISPHOSPHONATE COMPOSITIONS
- Publication number 20120128780
- Publication date May 24, 2012
- Elan Pharma International Ltd.
- Gary G. Liversidge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Novel mometasone compositions and methods of making and using the same
- Publication number 20120121653
- Publication date May 17, 2012
- ELAN PHARMA INTERNATIONAL LIMITED
- Scott Jenkins
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
STABLE LIQUID FORMULATIONS OF ANTI-INFECTIVE AGENTS AND ADJUSTED AN...
- Publication number 20120115836
- Publication date May 10, 2012
- Gary Liversidge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NANOPARTICULATE STABILIZED ANTI-HYPERTENSIVE COMPOSITIONS
- Publication number 20120076863
- Publication date Mar 29, 2012
- Elan Pharma International Ltd.
- Scott Jenkins
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS FOR SITE-SPECIFIC DELIVERY OF IMATINIB AND METHODS OF USE
- Publication number 20120003319
- Publication date Jan 5, 2012
- ELAN PHARMA INTERNATIONAL LIMITED
- Gary Liversidge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CONTROLLED RELEASE NANOPARTICULATE CLOZAPINE COMPOSITIONS
- Publication number 20110300210
- Publication date Dec 8, 2011
- ELAN PHARMA INTERNATIONAL LIMITED
- Jon Swanson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ALCOHOL RESISTANT ENTERIC PHARMACEUTICAL COMPOSITIONS
- Publication number 20110223244
- Publication date Sep 15, 2011
- ELAN PHARMA INTERNATIONAL LIMITED
- Gary Liversidge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INJECTABLE NANOPARTICULATE OLANZAPINE FORMULATIONS
- Publication number 20110195095
- Publication date Aug 11, 2011
- Gary Liversidge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NANOPARTICULATE BICALUTAMIDE FORMULATIONS
- Publication number 20110159054
- Publication date Jun 30, 2011
- Elan Pharma International Ltd.
- Scott JENKINS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NANOPARTICULATE AND CONTROLLED RELEASE COMPOSITIONS COMPRISING CYCL...
- Publication number 20110064800
- Publication date Mar 17, 2011
- Scott A. Jenkins
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NANOPARTICULATE AND CONTROLLED RELEASE COMPOSITIONS COMPRISING VITA...
- Publication number 20110064803
- Publication date Mar 17, 2011
- ELAN PHARMA INTERNATIONAL LIMITED
- John G. Devane
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Nanoparticulate statin formulations and novel statin combinations
- Publication number 20110027371
- Publication date Feb 3, 2011
- ELAN PHARMA INTERNATIONAL LIMITED
- Eugene R. Cooper
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Nanoparticulate and Controlled Release Compositions Comprising Aryl...
- Publication number 20110008435
- Publication date Jan 13, 2011
- Elan Corporation plc
- John G. Devane
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Nanoparticulate and controlled release compositions comprising nilv...
- Publication number 20100247636
- Publication date Sep 30, 2010
- ELAN CORPORATION, plc
- John G. Devane
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Nanoparticulate azelnidipine formulations
- Publication number 20100221327
- Publication date Sep 2, 2010
- ELAN PHARMA INTERNATIONAL LIMITED
- Scott Jenkins
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NANOPARTICULATE POLYCOSANOL FORMULATIONS & NOVEL POLYCOSANOL COMBIN...
- Publication number 20100143962
- Publication date Jun 10, 2010
- Elan Pharma International Ltd.
- Eugene R. COOPER
- A23 - FOODS OR FOODSTUFFS THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
Information Patent Application
Modified Release Famciclovir Compositions
- Publication number 20100136106
- Publication date Jun 3, 2010
- Gary Liversidge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Nanoparticulate stabilized anti-hypertensive compositions
- Publication number 20100028439
- Publication date Feb 4, 2010
- ELAN PHARMA INTERNATIONAL LIMITED
- Scott Jenkins
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION OF A TRIPTAN AND AN NSAID
- Publication number 20090311335
- Publication date Dec 17, 2009
- Scott Jenkins
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AEROSOL AND INJECTABLE FORMULATIONS OF NANOPARTICULATE BENZODIAZEPINE
- Publication number 20090304801
- Publication date Dec 10, 2009
- ELAN PHARMA INTERNATIONAL LIMITED
- Gary Liversidge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Nanoparticulate and Controlled Release Compositions Comprising a Pl...
- Publication number 20090297596
- Publication date Dec 3, 2009
- Elan Pharma International Limited
- John Devane
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NANOPARTICULATE ANTICONVULSANT AND IMMUNOSUPPRESSIVE COMPOSITIONS
- Publication number 20090297619
- Publication date Dec 3, 2009
- Elan Pharma International Ltd.
- Jon Swanson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Gary G. Liversidge

Person

Patents Grantslast 30 patents

Abuse-resistant pharmaceutical compositions

Nanoparticulate carverdilol formulations

Nanoparticulate quinazoline derivative formulations

Controlled-release nanoparticulate compositions

Glipizide compositions

Nanoparticulate bisphosphonate compositions

Nanoparticulate and controlled release compositions comprising cefd...

Nanoparticulate corticosteroid and antihistamine formulations metho...

Injectable nanoparticulate olanzapine formulations

Nanoparticulate and controlled release compositions comprising cycl...

Reduction of intravenously administered nanoparticulate-formulation...

Nanoparticulate polycosanol formulations and novel polycosanol comb...

Methods for targeting drug delivery to the upper and/or lower gastr...

Methods of treating mammals using nanocrystalline formulations of h...

Methods of making nanocrystalline formulations of human immunodefic...

Nanocrystalline formulations of human immunodeficiency virus (HIV)...

Reduction of intravenously administered nanoparticulate-formulation...

Formulations of oral gastrointestinal diagnostic x-ray contrast age...

Barium salt formulations stabilized by non-ionic and anionic stabil...

Formulations of oral gastrointestinal therapeutic agents in combina...

Site-specific adhesion within the GI tract using nanoparticles stab...

Surface modified NSAID nanoparticles

Surface modified anticancer nanoparticles

Formulations of oral gastrointestinal diagnostic X-ray contrast age...

X-ray contrast compositions useful in medical imaging

Surface modified anticancer nanoparticles

X-ray contrast compositions useful in medical imaging

Method to reduce particle size growth during lyophilization

Surface modified drug nanoparticles

Patents Applicationslast 30 patents

ALCOHOL RESISTANT ENTERIC PHARMACEUTICAL COMPOSITIONS

Multiparticulate Modified Release Composition

INJECTABLE NANOPARTICULATE OLANZAPINE FORMULATIONS

ALCOHOL RESISTANT ENTERIC PHARMACEUTICAL COMPOSITIONS

ABUSE-RESISTANT PHARMACEUTICAL COMPOSITIONS

Injectable Nanoparticulate Olanzapine Formulations

CONTROLLED RELEASE NANOPARTICULATE COMPOSITIONS

INJECTABLE NANOPARTICULATE OLANZAPINE FORMULATIONS

NANOPARTICULATE BISPHOSPHONATE COMPOSITIONS

Novel mometasone compositions and methods of making and using the same

STABLE LIQUID FORMULATIONS OF ANTI-INFECTIVE AGENTS AND ADJUSTED AN...

NANOPARTICULATE STABILIZED ANTI-HYPERTENSIVE COMPOSITIONS

COMPOSITIONS FOR SITE-SPECIFIC DELIVERY OF IMATINIB AND METHODS OF USE

CONTROLLED RELEASE NANOPARTICULATE CLOZAPINE COMPOSITIONS

ALCOHOL RESISTANT ENTERIC PHARMACEUTICAL COMPOSITIONS

INJECTABLE NANOPARTICULATE OLANZAPINE FORMULATIONS

NANOPARTICULATE BICALUTAMIDE FORMULATIONS

NANOPARTICULATE AND CONTROLLED RELEASE COMPOSITIONS COMPRISING CYCL...

NANOPARTICULATE AND CONTROLLED RELEASE COMPOSITIONS COMPRISING VITA...

Nanoparticulate statin formulations and novel statin combinations

Nanoparticulate and Controlled Release Compositions Comprising Aryl...

Nanoparticulate and controlled release compositions comprising nilv...

Nanoparticulate azelnidipine formulations

NANOPARTICULATE POLYCOSANOL FORMULATIONS & NOVEL POLYCOSANOL COMBIN...

Modified Release Famciclovir Compositions

Nanoparticulate stabilized anti-hypertensive compositions

COMBINATION OF A TRIPTAN AND AN NSAID

AEROSOL AND INJECTABLE FORMULATIONS OF NANOPARTICULATE BENZODIAZEPINE

Nanoparticulate and Controlled Release Compositions Comprising a Pl...

NANOPARTICULATE ANTICONVULSANT AND IMMUNOSUPPRESSIVE COMPOSITIONS